Zurich Finan Servs - TEB Sigorta A.S. in Turkey

* Reuters is not responsible for the content in this press release.

Mon Mar 31, 2008 12:15pm EDT

RNS Number:2124R
Zurich Financial Services
31 March 2008


Zurich closes acquisition of TEB Sigorta A.S. in Turkey


    Zurich Financial Services
                 Mythenquai 2
                  8022 Zurich
                  Switzerland
               www.zurich.com
   SWX Swiss Exchange/virt-x:
                         ZURN
             Valor: 001107539

              Media Relations
    Phone +41 (0)44 625 21 00
      Fax +41 (0)44 625 26 41
             media@zurich.com

           Investor Relations
    Phone +41 (0)44 625 22 99
      Fax +41 (0)44 625 36 18
investor.relations@zurich.com

Zurich, March 31, 2008 - Zurich Financial Services Group (Zurich) has announced
today the completion of the acquisition of 100% of general insurer TEB Sigorta
A.S. from TEB Mali Yatirimlar A.S. (TEB Mali). TEB Sigorta is one of the fastest
growing and most profitable general insurance companies in Turkey with a strong
focus on banc-assurance. After having announced this transaction on January 24,
2008, Zurich has now received all necessary regulatory approvals.

Zurich Financial Services Group (Zurich) is an insurance-based financial
services provider with a global network of subsidiaries and offices in North
America and Europe as well as in Asia Pacific, Latin America and other markets.
Founded in 1872, the Group is headquartered in Zurich, Switzerland. It employs
approximately 60,000 people serving customers in more than 170 countries.

For broadcast-standard video supporting this news release, please visit http://
www.thenewsmarket.com/zurich. If you are a first-time user, please take a moment
to register. In case you have any questions, please email
journalisthelp@thenewsmarket.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
ACQILFLRVTILVIT
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.